Research Grants 6 show all


$510.1K
2004

$556.3K
2005

$250K
2006

$210.7K
2009

Patents 525show all

  • 228
    A61K - Preparations for medical, dental, or toilet purposes
  • 159
    C07K - Peptides
  • 151
    C12N - Microorganisms or enzymes
  • 56
    G01N - Investigating or analysing materials by determining their chemical or physical properties
  • 50
    Y02A - Technologies for adaptation to climate change
  • 49
    A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
  • 43
    C07D - Heterocyclic compounds
  • 28
    C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganisms
  • 24
    C40B - Combinatorial chemistry
  • 18
    B01J - Chemical or physical processes, e.g. catalysis or colloid chemistry

Clinical Trials 16show all

6Phase 25Phase 1/Phase 23Phase 32Phase 1

SEC Filings show all


195
8-K

33
10-Q

12
D

11
10-K

1
S-1

Contact Information

Union City, CA
United States

SEC Form D Funding Events

DateOfferedSoldType
2012-12-13$10,000,000$0Equity
2012-06-06Indefinite$715,000Debt, Option to Acquire, Security to be Acquired, Other
2012-05-29Indefinite$4,473,673Equity, Option to Acquire, Security to be Acquired
2012-02-24Indefinite$1,047,500Debt, Option to Acquire, Security to be Acquired, Other
2011-11-15Indefinite$1,977,500Debt, Option to Acquire, Security to be Acquired, Other
2011-05-27Indefinite$6,016,250Debt, Option to Acquire, Security to be Acquired, Other
2010-11-15Indefinite$835,000Debt, Option to Acquire, Security to be Acquired, Other
2010-07-30$7,500,000$7,500,000Equity, Option to Acquire, Security to be Acquired
2009-10-22Indefinite$50,000Debt, Option to Acquire, Security to be Acquired
2009-10-05$5,000,000$5,000,000Option to Acquire, Security to be Acquired
2009-10-01Indefinite$961,650Debt, Option to Acquire, Security to be Acquired
2007-10-29Unknown Unknown Other (Paper Filing)

Key Executives

  • Thomas A. Moore
    Executive Officer, Director
  • Fredrick Cobb
    Executive Officer
  • John M. Rothman
    Executive Officer
  • Roni Appel
    Director
  • Thomas McKearn
    Director
  • James Patton
    Director
  • Richard Berman
    Director
  • Thomas Moore
    Director, Executive Officer
  • Roni A. Appel
    Director
  • John Rothman
    Executive Officer
  • Mark J. Rosenblum
    Executive Officer
  • Thomas L. McKearn
    Director